Given that TMPRSS2 is a promising drug target for SARS-CoV-2, this study aimed to investigate the expression profile, determine the prognostic potential of TMPRSS2, and estimate the association between TMPRSS2 and immune cell infiltration in lung cancer. The gene discussed is TMPRSS2; the disease is lung carcinoma.